Loading…
Aurinia Pharmaceuticals Inc. is projected to rise to $21.46 by 2027, a +38% move from its current price of $15.54. AUPH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $15.24 | $15.54 | $15.85 | +0.03% |
| May 30 | $15.12 | $15.55 | $15.99 | +0.06% |
| May 31 | $15.03 | $15.55 | $16.09 | +0.09% |
| Jun 1 | $14.96 | $15.56 | $16.18 | +0.12% |
| Jun 2 | $14.89 | $15.56 | $16.26 | +0.15% |
| Jun 3 | $14.84 | $15.57 | $16.33 | +0.18% |
| Jun 4 | $14.78 | $15.57 | $16.40 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.78 | $15.57 | $16.40 | +0.21% |
| Week 2 | $14.50 | $15.60 | $16.79 | +0.41% |
| Week 3 | $14.29 | $15.64 | $17.11 | +0.62% |
| Week 4 | $14.12 | $15.67 | $17.38 | +0.83% |
| Week 5 | $13.98 | $15.70 | $17.64 | +1.04% |
| Week 6 | $13.85 | $15.73 | $17.87 | +1.24% |
| Week 7 | $13.74 | $15.77 | $18.09 | +1.45% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis.
It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
Aurinia Pharmaceuticals Inc. trades at $15.22 with a market cap of $1.96B, and it ranks 2019. This places the stock among mid-sized healthcare names with a global focus on autoimmune diseases."
A major floor 10.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.6% away) — a key level to hold.
The nearest ceiling, 5.7% above — a clean break opens room to run.
A major ceiling 9.3% above — clearing it would confirm fresh momentum.
Key AUPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AUPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.46 | Buy | $15.44 | Buy |
| MA 10 | $15.56 | Sell | $15.51 | Buy |
| MA 20 | $15.59 | Sell | $15.58 | Sell |
| MA 50 | $15.45 | Buy | $15.45 | Buy |
| MA 100 | $15.07 | Buy | $15.06 | Buy |
| MA 200 | $14.28 | Buy | $13.94 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.51 | Neutral |
| Stoch RSI (14) | 49.66 | Neutral |
| CCI (20) | -11.12 | Neutral |
| Williams %R (14) | -55.06 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | 2.04 | Buy |
| Bollinger %B (20,2) | 0.46 | Neutral |
| Stochastic %K (14) | 44.94 | Neutral |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | -0.31 | Sell |
| Ultimate (7,14,28) | 51.70 | Neutral |
| Momentum (10) | -0.45 | Sell |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 15.26 | Buy |
| ADX (14) | 9.54 | Neutral |
| ATR (14) | 0.29 | Info |
RSI(14) is 50, signaling neutral near-term momentum. The stock trades above the 200-day moving average at $14.24, and just above the 50-day moving average of $15.40, which sits near current price action. Support is reported at $15.14 and resistance at $16.42, framing a near-term range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.95 | $15.54 | $20.96 | 0% | Neutral | |
| $17.49 | $21.46 | $27.61 | +38% | Bullish | |
| $21.87 | $27.35 | $36.14 | +76% | Bullish | |
| $24.45 | $31.07 | $41.94 | +100% | Bullish | |
| $28.79 | $37.09 | $50.99 | +139% | Bullish | |
| $30.77 | $40.15 | $56.09 | +158% | Bullish | |
| $31.68 | $41.82 | $59.26 | +169% | Bullish | |
| $36.65 | $48.92 | $70.24 | +215% | Bullish | |
| $42.28 | $57.01 | $82.86 | +267% | Bullish | |
| $49.50 | $67.40 | $99.09 | +334% | Bullish | |
| $67.34 | $95.83 | $147.81 | +517% | Bullish | |
| $147.57 | $226.05 | $374.44 | +13.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $13.95 | $15.54 | $18.16 | +0.00% |
| June 2026 | $13.43 | $15.68 | $18.66 | +0.89% |
| July 2026 | $13.59 | $15.96 | $19.19 | +1.82% |
| August 2026 | $13.36 | $15.77 | $19.10 | -1.23% |
| September 2026 | $13.37 | $15.83 | $19.30 | +0.41% |
| October 2026 | $13.92 | $16.55 | $20.28 | +4.50% |
| November 2026 | $14.22 | $16.96 | $20.88 | +2.48% |
| December 2026 | $14.17 | $16.94 | $20.96 | -0.08% |
Click any year to see its month-by-month AUPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, AUPH is projected to trade between $13.95 and $20.96, averaging $15.54 — a potential gain of 0% from today's $15.54. A consolidation phase looks the most probable path here.
Aurinia Pharmaceuticals Inc.'s 2027 outlook centres on $21.46, within a $17.49 to $27.61 range. That is up +38% on the projected 2026 average. That marks a +38% change versus current levels. Momentum favours further upside here.
By 2028, AUPH could reach as high as $36.14, with a base case around $27.35 and support toward $21.87 — roughly +76% from $15.54. Buyers look set to stay in control over this stretch.
Expect AUPH to range from $24.45 to $41.94 through 2029. The $31.07 average target implies a +100% move from current prices. That is up +14% on the projected 2028 average. Momentum favours further upside here.
The AUPH price prediction for 2030 points to an average of $37.09 (low $28.79, high $50.99) — a potential gain of +139% on today's $15.54. Buyers look set to stay in control over this stretch.
In 2031, AUPH is projected to trade between $30.77 and $56.09, averaging $40.15 — a potential gain of +158% from today's $15.54. That is up +8% on the projected 2030 average. Momentum favours further upside here.
Aurinia Pharmaceuticals Inc.'s 2032 outlook centres on $41.82, within a $31.68 to $59.26 range. That is up +4% on the projected 2031 average. That marks a +169% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, AUPH could reach as high as $70.24, with a base case around $48.92 and support toward $36.65 — roughly +215% from $15.54. Momentum favours further upside here.
Expect AUPH to range from $42.28 to $82.86 through 2034. The $57.01 average target implies a +267% move from current prices. That is up +17% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The AUPH price prediction for 2035 points to an average of $67.40 (low $49.50, high $99.09) — a potential gain of +334% on today's $15.54. Momentum favours further upside here.
In 2040, AUPH is projected to trade between $67.34 and $147.81, averaging $95.83 — a potential gain of +517% from today's $15.54. That is up +42% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Aurinia Pharmaceuticals Inc.'s 2050 outlook centres on $226.05, within a $147.57 to $374.44 range. That is up +136% on the projected 2040 average. That marks a +13.5x change versus current levels. Momentum favours further upside here.
Investing $1,000 in AUPH today (≈ 64.350064 AUPH) could be worth
$14,546.46
+$13,546.46 (+1355%) by 2050 · US Dollar
Based on the average projected AUPH price of $226.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AUPHwould be worth at today's price.
$1,000 invested in AUPH on May 27, 2025 (≈ 122.699392 AUPH) would be worth
$1,906.75
+$906.75 (+90.7%) today · 1.91× · US Dollar
Based on a AUPH entry price of $8.15 vs. today's $15.54.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.9 | $977.36 | -2.3% |
| 1 month ago | $16.37 | $949.3 | -5.1% |
| 3 months ago | $13.97 | $1,112.38 | +11.2% |
| 6 months ago | $16.12 | $964.02 | -3.6% |
| 1 year ago | $8.15 | $1,906.75 | +90.7% |
| All time (5.0y) ago | $14.14 | $1,099.01 | +9.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AUPH forecast.
Our base-case forecast reaches $31.00 around 2029.
Implied market cap at $31.00: $3.99B
The multi-year forecast shows a path of rising averages and bullish sentiment from 2027 onward. The 2026 forecast average is $15.22 with a neutral sentiment and ROI 0. By 2030, the forecast average rises to $35.20 with a bullish sentiment and ROI 131.3.
The 2040 forecast average is $86.54 with a bullish sentiment and ROI 468.6, and by 2050 the average is $202.61 with a bullish sentiment and ROI 1231.2. These figures imply substantial upside potential over the long term, but they come with wide possible outcomes (min and max values listed for each year). The outlook assumes estimates rather than guarantees, and risks remain inherent in forward-looking forecasts.
Tap a question to reveal the answer.
The 2030 forecast specifies an average price of $35.20, with a min of $27.19 and a max of $48.68, and an ROI of 131.3. The sentiment is BULLISH.
Forecasts show bullish sentiment from 2027 onward, with the average price rising to $35.20 by 2030, $86.54 by 2040, and $202.61 by 2050, and ROIs of 131.3, 468.6, and 1231.2 respectively. The 2026 average is $15.22 with ROI 0, indicating no immediate gain expected in that year.
According to the forecast, the 2030 max is $48.68, while later years show higher potential with a 2035 max of $91.62 and a 2040 max of $134.74, eventually reaching $339.40 by 2050. So $60 could be possible in later years, not by 2030.
No. The 2030 max is $48.68.
Current price is $15.22 and market cap is $1.96B.
Aurinia Pharmaceuticals Inc. Community Discussion
0Share your Aurinia Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.